Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM. (2015)
Attributed to:
Functional characterisation of a novel BRCA1-mRNA splicing complex that is mutated in multiple cancers.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-14-3502
PubMed Identifier: 25870146
Publication URI: http://europepmc.org/abstract/MED/25870146
Type: Journal Article/Review
Volume: 75
Parent Publication: Cancer research
Issue: 11
ISSN: 0008-5472